pseudobulbar

pseudobulbar

 [soo″do-bul´bar]
apparently, but not really, due to a bulbar lesion.

pseu·do·bul·bar

(sū'dō-bŭl'bar),
Denoting a supranuclear paralysis of the bulbar nerves.

pseudobulbar

/pseu·do·bul·bar/ (-bul´bar) apparently, but not really, due to a bulbar lesion.

pseu·do·bul·bar

(sū'dō-bŭl'bahr)
Denoting a supranuclear paralysis of the bulbar nerves.

pseudobulbar

apparently, but not really, due to a lesion of the medulla oblongata.
References in periodicals archive ?
today announced that data on the prevalence of symptoms for pseudobulbar affect (PBA), a distressing condition characterized by sudden and uncontrollable outbursts of laughing and/or crying resulting from certain neurologic diseases or brain injury (TBI), and the use of antipsychotic medications in nursing home residents, were recently published in the International Journal of Geriatric Psychiatry.
The acquisition integrates the buyer's psychiatric products, led by the anti-psychotic AbilifyA (aripiprazole), with Avanir's marketed Nuedexta, a mix of dextromethorphan and quinidine that is FDA's first approved treatment indicated for Pseudobulbar Affect (PBA), and several Avanir drug candidates.
ORLANDO -- The prevalence of pseudobulbar affect symptoms--that is, uncontrollable, disruptive outbursts of crying and/or laughing--is considerably greater across a range of neurologic disorders than previously appreciated, according to the largest-ever study to screen for this condition.
The involuntary giggling is known as pseudobulbar affect and is thought to be caused by disruptions to nerves during surgery.
Enna's constant giggling is called the Pseudobulbar effect - where patients who have had brain tumour surgery often express involuntary emotions.
A combination of dextromethorphan hydrobromide and quinidine sulfate recently became the first treatment to be approved by the Food and Drug Administration for the treatment of pseudobulbar affect, based on a study of patients with amyotrophic lateral sclerosis and multiple sclerosis.
The medicine, Nuedexta, is the first approved to treat patients with multiple sclerosis or Lou Gehrig's disease who develop symptoms known as pseudobulbar affect that causes loss of emotional control, the FDA said.
AVANIR is currently in the process of submitting to the FDA a "rolling" new drug application for Neurodex for the treatment of pseudobulbar affect and expects to complete the submission by June 30, 2005.
Neurologic disorders such as Arnold-Chiari malformation, myotonic dystrophy, pseudobulbar palsy, pharyngeal paresis, myasthenia gravis, and neurofibromatosis
Thousands of patients have benefited from NUEDEXTA since its launch in 2011 and this decision gives us the opportunity to continue helping those suffering from pseudobulbar affect (PBA) for many years to come," said Keith A.
A biopharmaceutical firm specializing in central nervous system (CNS) diseases, Avanir is the manufacturer of Nuedexta, the only FDA-approved treatment for the neurological disease pseudobulbar affect (PBA).
Patients were given a test measuring how often they laughed or cried unintentionally due to a neural disorder known as pseudobulbar affect.